文献速递乳腺癌放疗

乳腺导管原位癌保乳术后放疗美容效果的国际比较

International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast.
PubMed 文献 · Radiother Oncol · 2019-08-17

该研究基于一项随机III期试验,评估了1608例非低危乳腺导管原位癌(DCIS)患者保乳手术(BCS)后全乳放疗(WBI)分割方式及瘤床加量(TBB)对美容效果的影响。主要发现:TBB(16 Gy/8次)与美容恶化风险增加2倍以上相关(p < 0.001);大分割WBI(42.5 Gy/16次)与常规WBI(50 Gy/25次)的3年美容效果相似(p ≥ 0.18)。

要点

  • 瘤床加量16 Gy/8次使美容恶化风险增加2倍以上(p < 0.001)。
  • 大分割WBI与常规WBI的3年美容效果相似(p ≥ 0.18)。
  • TBB的不良影响与WBI分割方式无显著交互作用(交互p ≥ 0.30)。

核心结论

  • 保乳术后美容失败率在国际各辖区间相似。
  • 瘤床加量16 Gy增加美容恶化率。
  • 大分割WBI与常规WBI在DCIS保乳术后3年美容效果相似。

研究设计与样本

  • 随机III期试验,评估非低危DCIS保乳术后WBI ± TBB的美容影响。
  • 纳入2007至2014年间11个国家1608例女性。
  • 采用EORTC美容评分系统和数字图像评估基线与3年美容效果。

主要发现

  • 85-90%患者基线美容效果为优或良,与地理区域或评估方法无关。
  • TBB(16 Gy/8次)与美容恶化风险增加2倍以上相关(p < 0.001)。
  • 大分割WBI(42.5 Gy/16次)与常规WBI(50 Gy/25次)的3年美容效果统计学相似(p ≥ 0.18)。
  • TBB的不良影响与WBI分割方式无显著交互作用(交互p ≥ 0.30)。

关键数值与推荐

  • 美容失败定义为全局评分为一般或差。
  • 美容恶化定义为基线优或良变为3年时一般或差。
  • TBB剂量为16 Gy分8次。
  • 大分割WBI为42.5 Gy分16次,常规WBI为50 Gy分25次。

临床怎么用

  • DCIS保乳术后选择大分割WBI可获得与常规分割相似的3年美容效果。
  • 应用瘤床加量时需权衡美容恶化风险增加2倍以上。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess the cosmetic impact of breast conserving surgery (BCS), whole breast irradiation (WBI) fractionation and tumour bed boost (TBB) use in a phase III trial for women with ductal carcinoma in situ (DCIS) of the breast. MATERIALS AND METHODS: Baseline and 3-year cosmesis were assessed using the European Organization for Research and Treatment of Cancer (EORTC) Cosmetic Rating System and digital images in a randomised trial of non-low risk DCIS treated with postoperative WBI +/- TBB. Baseline cosmesis was assessed for four geographic clusters of treating centres. Cosmetic failure was a global score of fair or poor. Cosmetic deterioration was a score change from excellent or good at baseline to fair or poor at three years. Odds ratios for cosmetic deterioration by WBI dose-fractionation and TBB use were calculated for both scoring systems. RESULTS: 1608 women were enrolled from 11 countries between 2007 and 2014. 85-90% had excellent or good baseline cosmesis independent of geography or assessment method. TBB (16 Gy in 8 fractions) was associated with a >2-fold risk of cosmetic deterioration (p < 0.001). Hypofractionated WBI (42.5 Gy in 16 fractions) achieved statistically similar 3-year cosmesis compared to conventional WBI (50 Gy in 25 fractions) (p ≥ 0.18). The adverse impact of a TBB was not significantly associated with WBI fractionation (interaction p ≥ 0.30). CONCLUSIONS: Cosmetic failure from BCS was similar across international jurisdictions. A TBB of 16 Gy increased the rate of cosmetic deterioration. Hypofractionated WBI achieved similar 3-year cosmesis as conventional WBI in women treated with BCS for DCIS.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Olivotto IA, Link E, Phillips C, et al. International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast. Radiother Oncol. 2019. PMID: 31431385. doi:10.1016/j.radonc.2019.07.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。